Colorectal cancer: Screening

Annals of Oncology

Volumn 16, Issue SUPPL. 2, 2005, Pages

  Labianca, R ^a   Beretta, G D ^a   Mosconi, S ^a   Milesi, L ^a   Pessi, M A ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BARIUM; DNA;

ADENOMATOUS POLYP; ARTICLE; BARIUM ENEMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CROHN DISEASE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; DNA DETERMINATION; DOUBLE CONTRAST RADIOGRAPHY; EARLY DIAGNOSIS; ENTERITIS; HIGH RISK PATIENT; HUMAN; META ANALYSIS; OCCULT BLOOD TEST; PRACTICE GUIDELINE; PRECANCER; PRIORITY JOURNAL; SIGMOIDOSCOPY; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FECES; HUMANS; MASS SCREENING; RISK ASSESSMENT; SIGMOIDOSCOPY;

EID: 21344453812     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdi730     Document Type: Article

References (34)

1. Jemal A, Murray T, Samuels A et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
2. Micheli A, Mugno E, Krogh V et al. Cancer prevalence in European registry areas. EUROPREVAL working group. Ann Oncol 2002; 13: 840-865.
3. Bray F, Sankila R, Ferlay J et al. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002; 38: 99-166.
4. Ciccolallo L, Capocaccia R, Colemann MP et al. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 2005; 54: 268-273.
5. Gatta G, Ciccolallo L, Capocaccia R et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 2003; 39: 2214-2222.
6. Winawer SJ, Fletcher RH, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines rationale - update based on new evidence. Gastroenterology 2003; 124: 544-560.
7. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371.
8. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecaloccult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477.
9. Kronberg O, Fenger C, Olsen J et al. Randormsed study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471.
10. Winawer SJ, Zauber AG, O'Brien MJ et al. The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup. Cancer 1992; 7 (Suppl 5): 1236-1245.
11. Faivre J, Tazi MA, Milan C et al. Controlled trial of faecal occult blood screening for colorectal cancer in Burgundy (France). Results of the first 9 years. Gastroenterology 1999; 116: A400.
12. Towler BP, Irwig L, Glasziou P et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult (Cochrane review). In: The Cochrane Library, Issue 4. Chichester (UK): John Wiley & Sons, Ltd 2004.
13. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med 1997; 126: 811-822.
14. Wallace MB, Kemp JA, Trnka YM et al. Is colonoscopy indicated for small adenomas found by screening flexible sigmoidoscopy? Ann Intern Med 1998; 129: 273-278.
15. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990; 113: 373-384.
16. Selby JV, Friedman GD, Quesenberry CP Jr et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-657.
17. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case-control study of 32,702 veterans. Ann Intern Med 1995; 123: 904-910.
18. Newcomb PA, Norfleet RG, Storer BE et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-1575.
19. Hawk ET, Levin B. Colorectal cancer prevention. J Clin Oncol 2005; 23: 378-391.
20. Brawley OW, Kramer BS. Cancer screening in theory and in practice. J Clin Oncol 2005; 23: 293-300.
21. Gondal G, Grotmol T, Hofstad B et al. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 2003; 38: 635-642.
22. Rex DK, Cutler CS, Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-28.
23. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Work-group. N Engl J Med 1993; 329: 1977-1981.
24. Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343: 162-168.
25. Imperiale TF, Wagner DR, Lin CY et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343: 169-174.
26. Pickhardt PJ, Choi JR, Hwang I et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 2191-2200.
27. Cotton PB, Duralski VL, Pineau BC et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonography for detection of colorectal neoplasia. JAMA 2004; 291: 1713-1719.
28. Smith RA PhD, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer. CA Cancer J Clin 2004; 54: 41-52.
29. US Preventive Services Task Force. Summaries for patients. Screening for colorectal cancer: recommendations from the United States Preventive Services Task Force. Ann Intern Med 2002; 137: I38.
30. Advisory Committee on Cancer Prevention. Recommendations on Cancer Screening in the European Union. Conference on Screening and Early detection of cancer. Vienna Meeting, November 1999.
31. Andreoni, B., Beretta, G., Blengini, C. et al. Basi scientifiche per la definizione di linee-guida in ambito clinico per i Tumori del Colon-Retto. Progetto Strategico ONCOLOGIA. A cura di CNR e MIUR, January 2004.
32. Beretta G, Carnaghi C, Cosimelli M et al. Linee-guida per le neoplasie del Colon-Retto. A cura di Associazione Italiana di Oncologia Medica (AIOM). Brescia: Intermedia Editore 2003.
33. Giardiello FM, Bresinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001; 121: 198-213.
34. American Medical Association and the American Gastroenterology Association. Identifying and Managing Risk for Hereditary Nonpolyposis Colorectal Cancer (HNPCC) and Endometrial Cancer. Chicago (IL): American Medical Association 2000.